J.A.R.J. Hulsman

1.8k total citations
26 papers, 1.4k citations indexed

About

J.A.R.J. Hulsman is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, J.A.R.J. Hulsman has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 18 papers in Pediatrics, Perinatology and Child Health and 8 papers in Oncology. Recurrent topics in J.A.R.J. Hulsman's work include Epilepsy research and treatment (19 papers), Pharmacological Effects and Toxicity Studies (18 papers) and Drug Transport and Resistance Mechanisms (8 papers). J.A.R.J. Hulsman is often cited by papers focused on Epilepsy research and treatment (19 papers), Pharmacological Effects and Toxicity Studies (18 papers) and Drug Transport and Resistance Mechanisms (8 papers). J.A.R.J. Hulsman collaborates with scholars based in Netherlands, United States and Belgium. J.A.R.J. Hulsman's co-authors include J.F.K. Huber, Marian Majoie, Danielle A.J.E. Lambrechts, Albert P. Aldenkamp, H. Bootsma, A. Schellekens, Marc de Krom, L. Diepman, L. Leenen and J. W. A. Meijer and has published in prestigious journals such as Analytical Chemistry, Journal of Chromatography A and Analytica Chimica Acta.

In The Last Decade

J.A.R.J. Hulsman

26 papers receiving 1.3k citations

Peers

J.A.R.J. Hulsman
Neville Ratnaraj United Kingdom
Manickam Aravagiri United States
A. W. Peck United Kingdom
Joseph F. Gardocki United States
Gerard Forrest United Kingdom
B. G. White United States
Neville Ratnaraj United Kingdom
J.A.R.J. Hulsman
Citations per year, relative to J.A.R.J. Hulsman J.A.R.J. Hulsman (= 1×) peers Neville Ratnaraj

Countries citing papers authored by J.A.R.J. Hulsman

Since Specialization
Citations

This map shows the geographic impact of J.A.R.J. Hulsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A.R.J. Hulsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A.R.J. Hulsman more than expected).

Fields of papers citing papers by J.A.R.J. Hulsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A.R.J. Hulsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A.R.J. Hulsman. The network helps show where J.A.R.J. Hulsman may publish in the future.

Co-authorship network of co-authors of J.A.R.J. Hulsman

This figure shows the co-authorship network connecting the top 25 collaborators of J.A.R.J. Hulsman. A scholar is included among the top collaborators of J.A.R.J. Hulsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A.R.J. Hulsman. J.A.R.J. Hulsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Majoie, Marian, Kim Rijkers, M. W. Berfelo, et al.. (2010). Vagus Nerve Stimulation in Refractory Epilepsy: Effects on Pro- and Anti-Inflammatory Cytokines in Peripheral Blood. NeuroImmunoModulation. 18(1). 52–56. 72 indexed citations
2.
Lambrechts, Danielle A.J.E., et al.. (2009). Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine. Seizure. 19(1). 36–39. 84 indexed citations
3.
Bootsma, H., Lukas J. A. G. Ricker, Yechiel A. Hekster, et al.. (2008). The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure. 18(5). 327–331. 99 indexed citations
4.
Bootsma, H., Aurin M. Vos, J.A.R.J. Hulsman, et al.. (2008). Lamotrigine in clinical practice: Long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy & Behavior. 12(2). 262–268. 20 indexed citations
5.
Bootsma, H., Lukas J. A. G. Ricker, L. Diepman, et al.. (2007). Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison. Seizure. 17(1). 19–26. 52 indexed citations
6.
Bootsma, H., Lukas J. A. G. Ricker, L. Diepman, et al.. (2007). Levetiracetam in clinical practice: Long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy & Behavior. 10(2). 296–303. 87 indexed citations
7.
Aldenkamp, Albert P., L. Diepman, J.A.R.J. Hulsman, et al.. (2006). The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice. Epilepsia. 47(s2). 24–27. 34 indexed citations
8.
Hulsman, J.A.R.J., et al.. (2006). Lamotrigine in dried blood spots by HPLC. 3 indexed citations
9.
Bootsma, H., Frank P. A. Coolen, Albert P. Aldenkamp, et al.. (2004). Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy & Behavior. 5(3). 380–387. 57 indexed citations
10.
Aldenkamp, Albert P., Johan Arends, H. Bootsma, et al.. (2002). Randomized Double‐blind Parallel‐group Study Comparing Cognitive Effects of a Low‐dose Lamotrigine with Valproate and Placebo in Healthy Volunteers. Epilepsia. 43(1). 19–26. 72 indexed citations
12.
Aldenkamp, Albert P., J.A.R.J. Hulsman, Marian Majoie, et al.. (1998). Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates. European Journal of Clinical Pharmacology. 54(2). 185–192. 20 indexed citations
13.
Hulsman, J.A.R.J., Christopher Banfield, Pascale Reidenberg, et al.. (1995). Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. Clinical Pharmacology & Therapeutics. 58(4). 383–389. 17 indexed citations
14.
Hulsman, J.A.R.J., et al.. (1992). Loreclezole monotherapy in patients with partial seizures. Epilepsy Research. 11(2). 141–145. 6 indexed citations
15.
Hulsman, J.A.R.J., et al.. (1991). Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients. Epilepsy Research. 8(2). 166–169. 8 indexed citations
18.
Eve, Malcolm D., et al.. (1991). The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine. Clinical Pharmacology & Therapeutics. 50(4). 410–419. 65 indexed citations
19.
Lammertsma, Adriaan A., et al.. (1987). Oxcarbazepine (GP 47.680): A Possible Alternative to Carbamazepine?. Epilepsia. 28(6). 693–698. 127 indexed citations
20.
Meijer, J. W. A., et al.. (1980). Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side Effects. Epilepsia. 21(4). 341–350. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026